1. GloboCan 2012http://globocan.iarc.fr/.
2. US National Cancer Institute Surveillance, Epidemiology, and End Results Program.
3. Ahmed, F. et al. Prev. Chronic Dis. 5, A74 (2008).
4. Parkin, D. M., Ohshima, H., Srivatanakul, P. & Vatanasapt, V. Cancer Epidemiol. Biomarkers Prev. 2, 537–544 (1993).
5. Larsson, S. C . & Wolk, A. Br. J. Cancer 97, 1005–1008 (2007).